ArticleBioorganic & medicinal chemistry letters2019

Development of substituted pyrido[3,2-d]pyrimidines as potent and selective dihydrofolate reductase inhibitors for pneumocystis pneumonia infection.

Khushbu Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.